GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...
Hosted on MSN9mon
Senator slams GlaxoSmithKline over cost of asthma inhalersPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the ...
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...
Punchng on MSN5mon
Fake, unregistered asthma inhalers flood markets after GSK’s exitA year after British pharmaceutical giant, GlaxoSmithKline exited Nigeria and asthmatic patients who depended on its inhalers ...
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...
Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...
HealthDay on MSN12d
FDA Adds Warning Label to RSV Vaccines Abrysvo and ArexvyThe U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less complex and less ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback